NASDAQ Stocks
· May 23, 2025 11:12 AM EDT
Not market news
Tiziana Life Sciences Announces Breakthrough Advancement in Moderate Alzheimer’s Treatment with Intranasal Foralumab
Tiziana Life Sciences reports progress in Alzheimer's treatment using intranasal foralumab, showing promising results in patient trials.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
